Eosinophils are increasingly recognized as active players in the pathogenesis of IBD (94, 95), as these cells could contribute to mucosal damage through the release of cytotoxic granules, cytokines (e.g., IL−5, IL−13), and ROS (95, 96). This evidence concerns the gene IL13 and inflammatory bowel disease.